A randomized clinical study to evaluate the possible antifibrotic effect of zinc sulfate in chronic HCV patient receiving direct-acting anti-viral therapy

Authors

Institutions

Publication Details

Journal
Inflammopharmacology
Published
2025-01-01
DOI
https://doi.org/10.1007/s10787-024-01628-3
Citations
2
Primary Topic
Hepatitis C virus research
Type
article
Field-Weighted Citation Impact
2.64

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A randomized clinical study to evaluate the possible antifibrotic effect of zinc sulfate in chronic HCV patient receiving direct-acting anti-viral therapy

Dina S. Attalla, Dalia El‐Afify, Mostafa Elhelbawy, Sahar M. El-Haggar
2 citations
Inflammopharmacology
Hepatitis C virus research
2.64
article

A randomized clinical study to evaluate the possible antifibrotic effect of zinc sulfate in chronic HCV patient receiving direct-acting anti-viral therapy

Dina S. Attalla, Dalia El‐Afify, Mostafa Elhelbawy, Sahar M. El-Haggar
article en
2 citations

Abstract

No abstract available for this paper.
InflammopharmacologyVol. 33(1)
Tanta University (EG), Menoufia University (EG)
Tanta University
Good health and well-being
Openalex Percentile: Top 13%
Hepatitis C virus research
2.64
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A randomized clinical study to evaluate the possible antifibrotic effect of zinc sulfate in chronic HCV patient receiving direct-acting anti-viral therapy — Dina S. Attalla, Dalia El‐Afify, et al. · Inflammopharmacology (2025) | TGRS Research Map | TGRS